These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3360698)

  • 21. In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Meyer RD; Liu S
    Chemotherapy; 1986; 32(5):425-30. PubMed ID: 3093154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
    Van Caekenberghe D
    J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys.
    Gerchman I; Lysnyansky I; Perk S; Levisohn S
    Vet Microbiol; 2008 Oct; 131(3-4):266-76. PubMed ID: 18534788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 26. A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin.
    Schmitt K; Däubener W; Bitter-Suermann D; Hadding U
    J Immunol Methods; 1988 Apr; 109(1):17-25. PubMed ID: 3282011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus.
    van Rensburg CE; Joone G; Anderson R
    J Med Microbiol; 1990 May; 32(1):15-7. PubMed ID: 2111406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
    Salfinger M; Hohl P; Kafader FM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland.
    Kasprzykowska U; Sobieszczańska B; Duda-Madej A; Secewicz A; Nowicka J; Gościniak G
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():44-49. PubMed ID: 29154180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
    Uphoff CC; Meyer C; Drexler HG
    Leukemia; 2002 Feb; 16(2):284-8. PubMed ID: 11840296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory effect of various antiseptics, analgesics and lubricants on mycoplasmas.
    Furr PM; Taylor-Robinson D
    J Antimicrob Chemother; 1981 Aug; 8(2):115-9. PubMed ID: 7275881
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluoroquinolone antimicrobial agents.
    Wolfson JS; Hooper DC
    Clin Microbiol Rev; 1989 Oct; 2(4):378-424. PubMed ID: 2680058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin.
    Fallon RJ; Brown WM
    J Antimicrob Chemother; 1985 Jun; 15(6):787-9. PubMed ID: 3161857
    [No Abstract]   [Full Text] [Related]  

  • 36. In-vitro activity of gatifloxacin, a novel fluoroquinolone, compared with that of ciprofloxacin against Legionella spp.
    Pendland SL; Losnedahl KJ; Schriever CA
    J Antimicrob Chemother; 1999 Aug; 44(2):295-7. PubMed ID: 10473243
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Freeman S; Wormuth J; Cornett J
    Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
    [No Abstract]   [Full Text] [Related]  

  • 39. In-vitro sensitivity of legionellas and mycoplasmas to amifloxacin.
    Fallon RJ
    J Antimicrob Chemother; 1988 Mar; 21(3):381-2. PubMed ID: 3360698
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.